Health care spending accounts for nearly 1/5 of U.S. GDP. With changes coming fast and furious, it has become increasingly difficult to stay afloat without a steady hand on the tiller. With one of the largest health care practices in the U.S. whose lawyers are fully committed to the industry, Alston & Bird is well-positioned to help you navigate the latest regulations, policies, and trends.
Nuvectis Pharma Closes $16 Million Initial Public Offering of Common Stock
Alston & Bird client Nuvectis Pharma Inc., an oncology-focused biopharmaceutical company based in Fort Lee, NJ, has announced the closing of its initial public offering (IPO) of 3.2 million shares of common stock at a price of $5 per share, for gross proceeds of $16 million before deducting underwriting discounts and offering expenses. All shares of common stock were offered by Nuvectis.
Digital Transformation of Health Care
Alston & Bird works with clients on the forefront of the digital transformation of health care.